Journey Medical (DERM) Cost of Revenue: 2020-2025
Historic Cost of Revenue for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $5.8 million.
- Journey Medical's Cost of Revenue rose 28.72% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 9.30%. This contributed to the annual value of $20.9 million for FY2024, which is 8.80% down from last year.
- Journey Medical's Cost of Revenue amounted to $5.8 million in Q3 2025, which was up 16.52% from $4.9 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Cost of Revenue ranged from a high of $11.2 million in Q3 2021 and a low of $2.2 million during Q4 2023.
- In the last 3 years, Journey Medical's Cost of Revenue had a median value of $5.7 million in 2024 and averaged $5.4 million.
- In the last 5 years, Journey Medical's Cost of Revenue soared by 230.48% in 2021 and then tumbled by 70.87% in 2023.
- Quarterly analysis of 5 years shows Journey Medical's Cost of Revenue stood at $9.5 million in 2021, then fell by 18.97% to $7.7 million in 2022, then slumped by 70.87% to $2.2 million in 2023, then skyrocketed by 108.19% to $4.7 million in 2024, then increased by 28.72% to $5.8 million in 2025.
- Its last three reported values are $5.8 million in Q3 2025, $4.9 million for Q2 2025, and $4.8 million during Q1 2025.